Standout Papers

External validation and comparison with other models of the International Metastatic Renal-... 2012 2026 2016 2021 706
  1. External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study (2013)
    Daniel Y.C. Heng, Wanling Xie et al. The Lancet Oncology
  2. Lifetime Cancer Risks in Individuals with GermlinePTENMutations (2012)
    Min-Han Tan, Jessica L. Mester et al. Clinical Cancer Research

Immediate Impact

2 by Nobel laureates 21 from Science/Nature 86 standout
Sub-graph 1 of 20

Citing Papers

Thirty years of NRF2: advances and therapeutic challenges
2025 Standout
Renal Cell Carcinoma
2024 Standout

Works of Min-Han Tan being referenced

Survival Outcome and Treatment Response of Patients with Late Relapse from Renal Cell Carcinoma in the Era of Targeted Therapy
2013
An Antioxidant Response Phenotype Shared between Hereditary and Sporadic Type 2 Papillary Renal Cell Carcinoma
2011

Author Peers

Author Last Decade Papers Cites
Min-Han Tan 1157 1363 686 16 2.3k
Timothy Eisen 1910 1803 999 17 3.5k
Carol Peña 867 898 485 9 2.3k
Jeffrey S. Humphrey 429 1097 774 34 2.4k
Gladys Urbanowitz 2175 1904 981 12 4.1k
Debasish Roychowdhury 2053 1453 858 19 3.0k
Amy E. McKee 586 672 333 36 2.2k
James R. Vasselli 1156 1599 1115 36 3.6k
Dana D. Hu‐Lowe 788 1734 775 33 3.0k
Erhan Gökmen 2198 2049 1259 54 3.3k
Paul Frewer 2160 1302 569 38 3.5k

All Works

Loading papers...

Rankless by CCL
2026